Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

薬物名（臨床試験情報から抽出）

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

指定難病告示番号

1

Avonex (interferon beta-1a), Biogen Idec Ltd
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

2

Avonex/Betaseron/Copaxone/Rebif

3件: Glatiramer,
Interferon beta-1a (Rebif Rebidose),
Interferon beta-1b

2件: Interferon beta-1b ,
Interferon beta-1a (Rebif (TN)) 💬

Name	Other Names
Interferon beta-1b	Interferon beta-1b (USAN/INN) Interferon beta-1b (genetical recombination) (JAN) Betaseron (TN) Extavia (TN) インターフェロンベータ-1b ベタフェロン
Interferon beta-1a	Interferon beta-1a (USAN) Interferon beta-1a (genetical recombination) (JAN) Avonex (TN) Rebif (TN) インターフェロンベータ-1a アボネックス

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

3

BG9418 (interferon beta-1a)
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

2件: 13, 97 💬

4

Human interferon beta 1a (Rebif)

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

5

Human interferon beta-1a and glatiramer acetate
(Rebif (TN))

4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

6

IFN-beta-1a (Rebif®)

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

7

IFN-ß-1a (Rebif®)

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

8

INTERFERON BETA-1A
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

4件: 13, 26, 96, 97 💬

告示番号	日本語名	英語名
13	多発性硬化症／視神経脊髄炎	Multiple sclerosis/Neuromyelitis optica
26	HTLV-1関連脊髄症	HTLV-1-associated myelopathy
96	クローン病;回腸末端炎	Crohn disease
97	潰瘍性大腸炎	Ulcerative colitis

9

Interferon beta-1a (Avonex)
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

10

INTERFERON BETA-1A (Avonex®)
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

11

Interferon beta-1a (current approved manufacturing process invloving FBS)
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

12

Interferon beta-1a (new process, manufactured without FBS)
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

13

Interferon beta-1a (Rebif)

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

14

Interferon beta-1a (Rebif®) alone

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

15

Interferon beta-1a 30 µg
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

16

Interferon beta-1a FBS-free/HSA free, RNF
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

17

Interferon beta-1a FBS-free/HSA-free
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

18

Interferon beta-1a FBS-free/HSA-free, RNF
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

19

Interferon beta-1a HSA+ biosimilar
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

20

Interferon beta-1a HSA-free biosimilar
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

21

Interferon beta-1a original
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

22

Interferon Beta-1A Prefilled Syringe
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

23

Interferon beta-1a, 30 µg/0.5 ml
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

24

New Formulation of rebif - human interferon beta-1a

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

25

PEGylated Interferon Beta-1a
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

26

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

27

Rebif (IFN beta-1a subcutaneous three times per week)

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

28

Rebif (IFN ß-1a subcutaneous three times per week)

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

29

Rebif (interferon beta 1a)

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

30

Rebif (Interferon beta-1a)

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

31

Rebif (interferon beta-1a), Merck Serono Europe Ltd

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

32

REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

33

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

34

Rebif 22 micrograms

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

35

Rebif 22 y 44 mcg

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

36

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

37

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

38

Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

39

REBIF 44 microgramos solución inyectable

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

40

REBIF 44 microgramos solución inyectable en jeringa precargada

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

41

Rebif 44 micrograms

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

42

Rebif 44 micrograms solution for injection

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

43

Rebif 44 micrograms solution for injection in pre-filled syringe

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

44

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

45

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

46

Rebif 8,8 µg, Rebif 22µg

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

47

Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

48

Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

49

Rebif New Formulation + ibuprofen PRN

1件: Ibuprofen

1件: Ibuprofen 💬

2件: PTGS1,
PTGS2 💬

23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬

1件: 13 💬

50

Rebif New Formulation + prophylactic Ibuprofen

1件: Ibuprofen

1件: Ibuprofen 💬

2件: PTGS1,
PTGS2 💬

23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬

1件: 13 💬

51

Rebif New Formulation 44mcg multidose cartridge

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

52

Rebif New Formulation Non Titrated

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

53

Rebif New Formulation Titrated

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

54

REBIF SC 12SIR 12000000UI44MCG

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

55

REBIF SC 12SIR 6000000UI 22MCG

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

56

REBIF*SC 12SIR 12000000UI44MCG

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

57

REBIF*SC 12SIR 6000000UI 22MCG

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

58

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

59

Rebif® (clone 484-39)

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

60

Rebif® New Formulation

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

61

Rebif® New Formulation (IFN-beta-1a, RNF)

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

62

Rebif® new formulation (RNF)

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

63

Rebif® New Formulation (RNF) using RebiSmartTM

1件: Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

64

Recombinant human interferon beta-1a
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 26 💬

65

SC interferon beta-1a
(Rebif (TN))

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬

66

VigantOL oil plus interferon beta-1a (Rebif)

2件: Human interferon beta,
Interferon beta-1a (Rebif Rebidose)

1件: Interferon beta-1a (Rebif (TN)) 💬

2件: IFNAR1,
IFNAR2 💬

18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬

1件: 13 💬